Anavex Life Sciences (AVXL) Research & Development (2016 - 2026)
Anavex Life Sciences (AVXL) reported Research & Development of -$4.71 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $9.96 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Research & Development (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Anavex Life Sciences' Research & Development came in at $11.44 million, down 72.7% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $37.59 million, down 10.1% from FY2024.
- Research & Development has a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- By fiscal year, Research & Development came in at $41.84 million in FY2024 (-4.3%), $43.72 million in FY2023 (+15.3%), $37.92 million in FY2022 (+15.0%) and $32.98 million in FY2021 (+30.7%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Research & Development in data going back to fiscal Q3 2016.
- Year over year, Research & Development gained in three of the last seven quarters, with an average decline of 18.4%.
- The high point for year-over-year Research & Development in five years was fiscal Q4 2021 (growth of 53.5%); the low point was fiscal Q2 2026 (a decline of 57.6%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $4.19 million (Q2 2026), $4.66 million (Q1 2026) and $7.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Anavex Life Sciences | 218.76 Mn | -261.31 Mn | - | -4.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.71 Mn |
| Mar 31, 2026 | 4.19 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 9.96 Mn |
| Mar 31, 2025 | 9.89 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 11.81 Mn |
| Mar 31, 2024 | 9.73 Mn |
| Dec 31, 2023 | 8.68 Mn |
| Sep 30, 2023 | 10.06 Mn |
| Jun 30, 2023 | 10.28 Mn |
| Mar 31, 2023 | 11.31 Mn |
| Dec 31, 2022 | 12.07 Mn |
| Sep 30, 2022 | 11.38 Mn |
| Jun 30, 2022 | 9.27 Mn |
| Mar 31, 2022 | 8.60 Mn |
| Dec 31, 2021 | 8.66 Mn |
| Sep 30, 2021 | 9.37 Mn |
API Access
Anavex Life Sciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();